{
  "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
  "docSlug": "246b804be07776f664c6b3d8600daf3e",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 39,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 24,
  "notes": "The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/14",
  "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
  "deckJsonHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96.json",
  "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.03,
        "y": 0.0013
      },
      "kind": "list",
      "text": "Target for Accelerated Approval in Second-Line NSCLC: 35% ORR, 6 months DoR. Target for Standard Approval: 20% improvement of OS vs. SoC",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9ab54e9-2649-42b4-bc77-01d3774de84b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.96,
        "x": 0.02,
        "y": 0.0038
      },
      "kind": "table",
      "text": "Comparison table of Indication, Target Population, Treatment, Expected Efficacy, Safety Profile, Administration, and Trial of Reference across three treatment arms.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae18cf98-2670-49da-bec4-935c4ad522d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "THIO-101 – TARGET PROFILE",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab30d837-93aa-4ddd-89b1-661116ceb6b1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 9,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
      "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
      "position": 0,
      "objective": "Is THIO effective in clinical trials?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}